Please enable JavaScript to continue using this application.

Compare $COYA vs $INO | Chartloom

Compare

$COYA vs $INO

Coya Therapeutics Inc · Inovio Pharmaceuticals Inc

COYA

Coya Therapeutics Inc

INO

Inovio Pharmaceuticals Inc

Compare $COYA vs $INO

Comparing Coya Therapeutics Inc and Inovio Pharmaceuticals Inc

COYACoya Therapeutics Inc

INOInovio Pharmaceuticals Inc

COYACoya Therapeutics Inc

Market cap

$116M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

35.49x

Rev growth (TTM)

1793.6%

YTD performance

-12.4%

52W performance

-21.6%

FCF yield

-15.3%

INOInovio Pharmaceuticals Inc

Market cap

$95M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.48x

Rev growth (TTM)

-100.0%

YTD performance

-32.0%

52W performance

-55.1%

FCF yield

-85.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COYA

INO

Detailed metrics comparison

COYA

Coya Therapeutics Inc

INO

Inovio Pharmaceuticals Inc

Market Cap

COYA$116M

INO$95M

Enterprise Value

COYA$73M

INO$63M

Price

COYA$4.95

INO$1.15

P/E Ratio

COYAN/A

INON/A

P/S Ratio

COYA14.48x

INO423.69x

EV/Sales

COYA9.10x

INO312.32x

EV/EBITDA

COYA0.00x

INO0.00x

P/B Ratio

COYA2.61x

INO27.44x

P/FCF Ratio

COYAN/A

INON/A

EV/FCF

COYA-4.10x

INO-0.78x

PEG Ratio

COYAN/A

INON/A

Forward P/E (NTM)

COYAN/A

INON/A

Forward P/S (NTM)

COYA35.49x

INO2.48x

Revenue (TTM)

COYA$8M

INO$0

Revenue Growth (YoY)

COYA1793.6%

INO-100.0%

Forward Rev Growth

COYA389.9%

INO7491.0%

Gross Margin (TTM)

COYA0.0%

INO58.9%

Operating Margin (TTM)

COYA0.0%

INO0.0%

EBITDA Margin (TTM)

COYA-259.8%

INO0.0%

Net Margin (TTM)

COYA-270.2%

INO0.0%

FCF Margin (TTM)

COYA-221.6%

INON/A

Net Income (TTM)

COYA$-22M

INO$-67M

FCF (TTM)

COYA$-18M

INO$-81M

EPS (TTM)

COYA-$0.92

INO-$0.83

ROE (TTM)

COYA-5332.0%

INO-19050.0%

ROA (TTM)

COYA-4748.0%

INO-11105.0%

ROIC (TTM)

COYA-5332.0%

INO-19050.0%

Cash

COYA$43M

INO$32M

Debt

COYA$0

INO$0

Net Cash/Debt

COYA$43M

INO$32M

Current Ratio (TTM)

COYA13.40x

INO1.00x

Quick Ratio (TTM)

COYA12.29x

INO0.92x

Debt/Equity (TTM)

COYA0.00x

INO0.00x

Debt/Assets (TTM)

COYA0.0%

INO0.0%

Interest Coverage (TTM)

COYAN/A

INON/A

Net Debt/EBITDA (TTM)

COYA0.00x

INO0.00x

Beta

COYA0.58

INO1.68

52W Performance

COYA-21.6%

INO-55.1%

YTD Performance

COYA-12.4%

INO-32.0%

% from 52W High

COYA-36.1%

INO-57.7%

% from 52W Low

COYA33.4%

INO104.2%

Asset Turnover (TTM)

COYA0.18x

INO0.00x

FCF Yield (TTM)

COYA-15.3%

INO-85.4%

Earnings Yield (TTM)

COYA-18.7%

INO-71.3%

Dividend Yield (TTM)

COYAN/A

INON/A

Rule of 40

COYA1,571.9

INO-100.0

EV/GP/RG

COYAN/A

INON/A

Ticker research

View COYA research View INO research

Metric	COYA Coya Therapeutics Inc	INO Inovio Pharmaceuticals Inc
Market & Valuation
Market Cap	$116M	$95M
Enterprise Value	$73M	$63M
Price	$4.95	$1.15
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	423.69x
EV/Sales	9.10x	312.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	27.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	2.48x
Revenue & Growth
Revenue (TTM)	$8M	$0
Revenue Growth (YoY)	1793.6%	-100.0%
Forward Rev Growth	389.9%	7491.0%
Profitability
Gross Margin (TTM)	0.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	0.0%
Net Margin (TTM)	-270.2%	0.0%
FCF Margin (TTM)	-221.6%	N/A
Net Income (TTM)	$-22M	$-67M
FCF (TTM)	$-18M	$-81M
EPS (TTM)	-$0.92	-$0.83
ROE (TTM)	-5332.0%	-19050.0%
ROA (TTM)	-4748.0%	-11105.0%
ROIC (TTM)	-5332.0%	-19050.0%
Financial Health
Cash	$43M	$32M
Debt	$0	$0
Net Cash/Debt	$43M	$32M
Current Ratio (TTM)	13.40x	1.00x
Quick Ratio (TTM)	12.29x	0.92x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	1.68
52W Performance	-21.6%	-55.1%
YTD Performance	-12.4%	-32.0%
% from 52W High	-36.1%	-57.7%
% from 52W Low	33.4%	104.2%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.00x
FCF Yield (TTM)	-15.3%	-85.4%
Earnings Yield (TTM)	-18.7%	-71.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View INO research

Valuation

P/S Ratio

COYA

14.48x

INO

423.69x

EV/FCF

COYA

-4.10x

INO

-0.78x

Growth & revenue

Revenue Growth TTM

COYA

1793.6%

INO

-100.0%

Forward Revenue Growth

INO

7491.0%

COYA

389.9%

Profitability & performance

Gross Margin

INO

58.9%

COYA

0.0%

ROE

COYA

-5332.0%

INO

-19050.0%

FCF Yield %

COYA

-15.3%

INO

-85.4%

52-Week Performance

COYA

-21.6%

INO

-55.1%

Detailed metrics comparison

COYA

Coya Therapeutics Inc

INO

Inovio Pharmaceuticals Inc

Market Cap

COYA$116M

INO$95M

Enterprise Value

COYA$73M

INO$63M

Price

COYA$4.95

INO$1.15

P/E Ratio

COYAN/A

INON/A

P/S Ratio

COYA14.48x

INO423.69x

EV/Sales

COYA9.10x

INO312.32x

EV/EBITDA

COYA0.00x

INO0.00x

P/B Ratio

COYA2.61x

INO27.44x

P/FCF Ratio

COYAN/A

INON/A

EV/FCF

COYA-4.10x

INO-0.78x

PEG Ratio

COYAN/A

INON/A

Forward P/E (NTM)

COYAN/A

INON/A

Forward P/S (NTM)

COYA35.49x

INO2.48x

Revenue (TTM)

COYA$8M

INO$0

Revenue Growth (YoY)

COYA1793.6%

INO-100.0%

Forward Rev Growth

COYA389.9%

INO7491.0%

Gross Margin (TTM)

COYA0.0%

INO58.9%

Operating Margin (TTM)

COYA0.0%

INO0.0%

EBITDA Margin (TTM)

COYA-259.8%

INO0.0%

Net Margin (TTM)

COYA-270.2%

INO0.0%

FCF Margin (TTM)

COYA-221.6%

INON/A

Net Income (TTM)

COYA$-22M

INO$-67M

FCF (TTM)

COYA$-18M

INO$-81M

EPS (TTM)

COYA-$0.92

INO-$0.83

ROE (TTM)

COYA-5332.0%

INO-19050.0%

ROA (TTM)

COYA-4748.0%

INO-11105.0%

ROIC (TTM)

COYA-5332.0%

INO-19050.0%

Cash

COYA$43M

INO$32M

Debt

COYA$0

INO$0

Net Cash/Debt

COYA$43M

INO$32M

Current Ratio (TTM)

COYA13.40x

INO1.00x

Quick Ratio (TTM)

COYA12.29x

INO0.92x

Debt/Equity (TTM)

COYA0.00x

INO0.00x

Debt/Assets (TTM)

COYA0.0%

INO0.0%

Interest Coverage (TTM)

COYAN/A

INON/A

Net Debt/EBITDA (TTM)

COYA0.00x

INO0.00x

Beta

COYA0.58

INO1.68

52W Performance

COYA-21.6%

INO-55.1%

YTD Performance

COYA-12.4%

INO-32.0%

% from 52W High

COYA-36.1%

INO-57.7%

% from 52W Low

COYA33.4%

INO104.2%

Asset Turnover (TTM)

COYA0.18x

INO0.00x

FCF Yield (TTM)

COYA-15.3%

INO-85.4%

Earnings Yield (TTM)

COYA-18.7%

INO-71.3%

Dividend Yield (TTM)

COYAN/A

INON/A

Rule of 40

COYA1,571.9

INO-100.0

EV/GP/RG

COYAN/A

INON/A

Ticker research

View COYA research View INO research

Metric	COYA Coya Therapeutics Inc	INO Inovio Pharmaceuticals Inc
Market & Valuation
Market Cap	$116M	$95M
Enterprise Value	$73M	$63M
Price	$4.95	$1.15
P/E Ratio	N/A	N/A
P/S Ratio	14.48x	423.69x
EV/Sales	9.10x	312.32x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.61x	27.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.10x	-0.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	35.49x	2.48x
Revenue & Growth
Revenue (TTM)	$8M	$0
Revenue Growth (YoY)	1793.6%	-100.0%
Forward Rev Growth	389.9%	7491.0%
Profitability
Gross Margin (TTM)	0.0%	58.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-259.8%	0.0%
Net Margin (TTM)	-270.2%	0.0%
FCF Margin (TTM)	-221.6%	N/A
Net Income (TTM)	$-22M	$-67M
FCF (TTM)	$-18M	$-81M
EPS (TTM)	-$0.92	-$0.83
ROE (TTM)	-5332.0%	-19050.0%
ROA (TTM)	-4748.0%	-11105.0%
ROIC (TTM)	-5332.0%	-19050.0%
Financial Health
Cash	$43M	$32M
Debt	$0	$0
Net Cash/Debt	$43M	$32M
Current Ratio (TTM)	13.40x	1.00x
Quick Ratio (TTM)	12.29x	0.92x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.58	1.68
52W Performance	-21.6%	-55.1%
YTD Performance	-12.4%	-32.0%
% from 52W High	-36.1%	-57.7%
% from 52W Low	33.4%	104.2%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.00x
FCF Yield (TTM)	-15.3%	-85.4%
Earnings Yield (TTM)	-18.7%	-71.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,571.9	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View COYA research	View INO research